Sign in
Taking peopleNo phase

BosSTENT ImpLant to trEat debilitatiNg Pulse-synchronous Tinnitus

Key facts

Who runs it
Sonorous NV, Inc
Where
Canada and France6 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
90 people, planned
Started
1 Feb 2026
Expected to end
Jul 2028
Type of study
Interventional
Treatments tested
  • BosSTENT implantation
Record updated
28 August 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 32 criteriaShow less

Who can take part

  • Male or female ≥18 - 80 years old
  • Able to provide informed consent to participate in the study
  • Severe or catastrophic PST (THI grade ≥ 4; THI score ≥ 58) that responds to jugular vein compression
  • Cerebral venous sinus stenosis with the following characteristics:; Transverse cerebral venous sinus; >50% stenosis by computed tomography venogram (CTV), magnetic resonance venogram (MRV), or catheter cerebral angiography; Vessel diameter amenable to sizing according to Table 1 below without the need to undersize
  • Attempted PST amelioration with at least one non-invasive therapy (i.e., refractory to non-invasive therapy)
  • Willing to comply with protocol requirements and return to the treatment center for all required clinical evaluations and follow-up
  • Life expectancy >12 months

Who cannot take part

  • Previously implanted stent in the target vessel
  • Contraindication to anticoagulant and/or antiplatelet therapy or thrombolytic drugs
  • Hypercoagulable state or hemorrhagic or coagulation deficiency refractory to medical therapy
  • Pregnant or nursing women (females of childbearing potential who are less than 45 years old must have a pregnancy test and provide written proof that they are not pregnant prior to inclusion)
  • Dural cerebral venous sinus stenosis secondary to an underlying condition (e.g. brain tumor) that may be treated by alternative established therapies (e.g., surgery, embolization)
  • History of severe allergy to contrast/contrast media or nickel
  • Dural arteriovenous fistula or arteriovenous malformation
  • History of untreated atrial fibrillation, untreated/uncontrollable hypertension, or other stroke factors
  • History of deep vein thrombosis or pulmonary embolism
  • History of heart failure, dilated cardiomyopathy, or congenital heart conditions
  • Evidence of an active systemic infection
  • Venous sinus thrombosis, jugular compression, venous aberrant or tortuous anatomy that would prevent the safe delivery and deployment of the BosSTENT to the target treatment zone
  • Otologic disorders that may confound PST assessments, including, but not limited to misophonia or hyperacusis
  • Suffered a stroke within the past 6 months
  • Other clinical conditions, that in the opinion of the Investigator significantly compromise the ability to perform a safe and/or effective procedure
  • Platelet count <100x109/L (100,000/µL)
  • Target vessel size that does not fall within the indicated range per Table 1 of the IFU
  • Non-pulse-synchronous tinnitus
  • Current diagnosis of papilledema
  • Arterial stenosis, dissection, or aneurysm
  • PST due to causes not related to cerebral venous sinus stenosis
  • Cerebral venous sinus diverticulum that, in the Investigator's opinion, requires treatment other than stenting (e.g., coiling)
  • Participation in another investigational protocol
  • Immuno-compromised
  • Incapacitated, mentally compromised or otherwise incapable of understanding and/or providing informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is evaluating the safety and clinical performance of the BosSTENT, a new stent designed specifically for treating pulse-synchronous tinnitus due to venous sinus stenosis. The study will evaluate the long-term safety of the BosSTENT as well as its impact on the severity of pulse-synchronous tinnitus.

The group in the trial

  • BosSTENTTreatment being tested

    Treatment: BosSTENT implantation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT07070089, who can take part
Record updated
28 August 2026